Only [177Lu]Lu-AMTG (α-methyl-L-tryptophan modification) revealed a high in vivo stability over time and thus, shows the highest therapeutic value among radiolabeled GRPR ligands, which has also been confirmed in cancer patients. The gene discussed is GRPR; the disease is cancer.